Evolve Additive Solutions Announces Strategic Partnership with alphacam to Provide STEP Parts Production in Europe
Evolve Additive Solutions, provider of industrial 3D printing solutions and inventor of the transformative Selective Thermoplastic Electrophotographic Process (STEP), announces a strategic partnership with alphacam GmbH to offer STEP-manufactured parts as a service to customers throughout Europe. STEP is a groundbreaking additive manufacturing technology that addresses the manufacturing constraints in accuracy, scalability and engineering-grade materials by other technologies in market today. alphacam will combine its deep industry expertise, vast experience in printing plastic parts, and strong customer relationships with its adoption of Evolve’s Scaled Volume Production (SVP) platform to produce and deliver fully dense, high-fidelity thermoplastic parts with near injection molding surface finish and properties.
This marks the 2nd partnership of this kind introduced by Evolve as part of its mission to establish STEP production centers of excellence around the world – ultimately to increase access to STEP technology as the only additive process today that can deliver on the material properties, accuracy, and scalability required to print end-use parts at production volumes and replace traditional manufacturing methods for more applications. The first partnership previously announced was with Fathom Digital Manufacturing, which currently offers STEP parts in North America and continues to experience rapid and expanding interest and growth in STEP from customers.
“We have experienced increasing demand for STEP parts in Europe, especially in automotive, consumer electronics, medical device and retail markets, as well as with fluid and airflow applications,” said Jeff Hanson, Evolve’s Senior Vice President of Go-to-Market. “Given their rich history and leadership in additive manufacturing, alphacam is the ideal partner to bring STEP technology to European industrial sectors.”
“At alphacam we pride ourselves on remaining at the forefront of advanced manufacturing technologies and services,” said Michael Junghanss, alphacam’s Managing Partner. “I believe STEP technology is uniquely positioned to deliver on additive manufacturing’s quest toward production quality and scale, and we are excited to now be able to deliver this value by way of STEP parts to our customers.”
alphacam unveiled its new STEP technology offering with great reception during its widely attended 2nd annual alphacAM EXPO and customer open house on September 27, 2023. STEP parts production is now available directly through alphacam.
About Evolve Additive Solutions
Evolve Additive Solutions is transforming how the world manufactures. Founded in 2017, the company offers Additive Manufacturing production equipment, materials, software, parts production, consulting, and application services. Evolve allows for manufacturing flexibility, creating uniquely functional products while increasing speed to market and efficiency securing supply chains. Evolve’s patented STEP technology is able to efficiently produce commercial grade production parts and create unique products that cannot be manufactured with traditional methods. The company is headquartered in Minnetonka, MN with a materials technology center based in Rochester, NY. More at: www.evolveadditive.com
About alphacam, GmbH
For more than 25 years, alphacam has been offering the complete range of products and services related to 3D printing and additive manufacturing - from the generation of 3D CAD data to the additive manufacturing of this data with the help of 3D printers and 3D production systems. alphacam's extensive offering includes the sales, consulting and service for industrial 3D printers and post-processing systems, professional plastic and metal 3D printing parts production services, and the sales and support of industrial CAD/CAM software. Owner-managed, flexible and fast, alphacam’s unique set of services and expertise ensure satisfaction of a continuously growing customer base. More at: www.alphacam.de
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231002368174/en/
Contact information
Cheryl Hillman
Sr. Marketing Manager, Evolve Additive Solutions
cheryl.hillman@evolveadditive.com
763-438-6569
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
PQE Group Joins Project-COMFORT to Advance Patient-Centric Blood Collection and Diagnostics30.12.2024 07:50:00 CET | Press Release
PQE Group, a global consulting firm specializing in Life Sciences, is proud to contribute its expertise as a strategic partner in the Project-COMFORT consortium. This innovative public-private partnership, funded by Horizon Europe and supported by the Innovative Health Initiative Joint Undertaking (IHI JU), officially launched in November 2024, marking a transformative shift in blood collection and diagnostics. The ambitious 42-month project brings together 51 organizations from a broad spectrum of sectors, including academia, research institutions, hospitals, foundations, SMEs, medical technology, and pharmaceutical companies, all united by the mission to simplify, reduce the invasiveness of, and increase accessibility to blood collection through cutting-edge, patient-centered microsampling technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241229266268/en/ Follow Project-Comfort LinkedIn Page: https://www.linkedin.
Medical-Fish-Skin Company Kerecis Expands Silicone Fish-Skin Combination Product Range for Surgical and Trauma Wound with SurgiClose® Silicone27.12.2024 20:00:00 CET | Press Release
Kerecis, the company pioneering the use of sustainably sourced fish skin and fatty acids in cellular therapy and tissue regeneration and protection, today announced the availability of SurgiClose® Silicone, which combines a fish-skin graft and silicone backing for efficient treatment of surgical and trauma wounds. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241227975454/en/ SurgiClose® Silicone (Photo: Business Wire) SurgiClose® Silicone is a part of the SurgiClose® product family, which is intact fish-skin intended for the management of trauma wounds and surgical wounds in the operating room. The new product is available in two variations, SurgiClose® Silicone Adhesive with borders that overlap the fish-skin underneath and SurgiClose® Silicone Standard with non-overlapping borders. “Applying Kerecis fish-skin to a surgical or trauma wound is a multi-step process that often requires supporting products such as sutures, st
TEVIMBRA Approved in U.S. for First-line Treatment of Gastric and Gastroesophageal Junction Cancers in Combination with Chemotherapy27.12.2024 12:00:00 CET | Press Release
BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company that intends to change its name to BeOne Medicines Ltd., today announced the U.S. Food and Drug Administration (FDA) has approved TEVIMBRA® (tislelizumab-jsgr), in combination with platinum and fluoropyrimidine-based chemotherapy, for the first-line treatment of unresectable or metastatic HER2-negative gastric or gastroesophageal junction adenocarcinoma (G/GEJ) in adults whose tumors express PD-L1 (≥1). “Today’s FDA approval of TEVIMBRA for the treatment of gastric or gastroesophageal junction cancers in PD-L1 positive adult patients marks a significant step forward in our mission to deliver transformative therapies to patients with cancer,” said Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeiGene. “This is the second U.S. approval for TEVIMBRA this year, underscoring its potential to address critical needs in oncology. We remain deeply grateful to the patients, clinicians, and resear
Takeda Announces Approval of HYQVIA ® 10% S.C. (Subcutaneous) Injection Set in Japan for Patients with Agammaglobulinemia or Hypogammaglobulinemia27.12.2024 07:00:00 CET | Press Release
Takeda (TSE:4502/NYSE:TAK) today announced that the Japanese Ministry of Health, Labour and Welfare has approved the use of HYQVIA® [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase] in patients with agammaglobulinemia or hypogammaglobulinemia1, disorders characterized by very low or absent levels of antibodies and an increased risk of serious recurring infection caused by primary immunodeficiency (PID) or secondary immunodeficiency (SID)2. The approval marks availability of the first and only facilitated subcutaneous immunoglobulin (fSCIG) therapy as a treatment option for appropriate patients in Japan. HYQVIA is the first plasma-derived therapy for subcutaneous injection in Japan that consists of a combination of one vial of Immunoglobulin 10% and one vial of Recombinant Human Hyaluronidase PH20 (rHuPH20). The administration of rHuPH20 increases the dispersion and absorption of immunoglobulin (IG) in the subcutaneous tissue, allowing larger volumes to be infu
Kolmar Korea Named One of the TIME’s World’s Best Companies for Sustainable Growth26.12.2024 15:00:00 CET | Press Release
Kolmar Korea (KRX: 024720) has been recognized by TIME Magazine as one of the World’s Best Companies for Sustainable Growth 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241226863828/en/ Kolmar Korea on TIME's World's Best Companies in Sustainable Growth 2025 (Image: Kolmar Korea) On November 27, TIME, in collaboration with a global market research firm Statista, unveiled a list of the top 500 companies worldwide, demonstrating exceptional sustainable growth. Kolmar Korea took place 125th around the globe and 6th among Korean companies. Notably, it was the only Korean cosmetics company on the list, which featured a total of 23 Korean companies. The rankings were based on an evaluation of revenue growth, financial stability, and environmental impact, each contributing equally to a final score out of 100 points. TIME and Statista analyzed 3,000 major companies from 150 countries, focusing exclusively on those with trans
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom